|View printer-friendly version|
|December 15, 2004 5:25 p.m.|
|Teva Announces Approval And Launch Of Gabapentin Tablets|
Jerusalem, Israel, December 15, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Gabapentin Tablets, 600 mg and 800 mg. Shipment of this product has commenced.